推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

[CITATION] Effect of screening on ovarian cancer mortality in the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer randomized screening trial

SS Buys, E Partridge… - Program and abstracts of the American Society of …, 2011
Cited by 1

Ovarian cancer: Model building

S Seton-Rogers - Nature Reviews Cancer, 2011 - nature.com
Although the prevailing hypothesis has been that high-grade serous ovarian carcinoma
(HGSOC) arises from ovarian surface epithelial cells, recent evidence suggests that around
50% of these tumours arise from fallopian tube secretory epithelial cells (FTSECs). ...
All 3 versions

DNA methylation markers associated with serous ovarian cancer subtypes

U Chandavarkar, M Campan… - GYNECOL …, 2011 - discovery.ucl.ac.uk
... DNA methylation markers associated with serous ovarian cancer subtypes. ... 10.1016/j.ygyno.
2010.12.117. Full text not available from this repository. Type: Article. Title: DNA methylation
markers associated with serous ovarian cancer subtypes. DOI: 10.1016/j.ygyno.2010.12.117. ...
Cached - All 2 versions

Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens

DW Cramer, RC Bast, CD Berg, EP Diamandis… - Cancer Prevention …, 2011 - AACR
Establishing a cancer screening biomarker's intended performance requires “phase III” specimens
obtained in asymptomatic individuals before clinical diagnosis rather than “phase II” specimens
obtained from symptomatic individuals at diagnosis. We used specimens from the ...
Cited by 13 - Related articles - All 4 versions

Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival

IA Silva, S Bai, K McLean, K Yang, K Griffith… - Cancer Research, 2011 - AACR
Markers that reliably identify cancer stem cells (CSC) in ovarian cancer could assist prognosis
and improve strategies for therapy. CD133 is a reported marker of ovarian CSC. Aldehyde dehydrogenase
(ALDH) activity is a reported CSC marker in several solid tumors, but it has not been ...
Cited by 3 - Related articles - All 3 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451